Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10% |
| 4 | Consumer Discretionary | 7.97% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
CALL
Canadian Natural Resources
CNQ
$97.8B
| – | – |
-24,100
| Closed | -$1.17M | – |
|
2977
Cohen & Steers
CNS
$3.86B
| – | – |
-3,572
| Closed | -$223K | – |
|
|
CNTA
2978
DELISTED
Centessa Pharmaceuticals
CNTA
| – | – |
-852,828
| Closed | -$33.9M | – |
|
2979
PUT
Vita Coco
COCO
$3.68B
| – | – |
-261,000
| Closed | -$12.5M | – |
|
2980
Choiceone Financial
COFS
$556M
| – | – |
-8,675
| Closed | -$244K | – |
|
2981
Collegium Pharmaceutical
COLL
$768M
| – | – |
-27,039
| Closed | -$894K | – |
|
2982
PUT
Vistance Networks Inc
VISN
$839M
| – | – |
-1,000,000
| Closed | -$18.2M | – |
|
2983
CALL
Global X Copper Miners ETF NEW
COPX
$6.11B
| – | – |
-226,500
| Closed | -$17.3M | – |
|
2984
Coursera
COUR
$950M
| – | – |
-50,391
| Closed | -$293K | – |
|
2985
Corbus Pharmaceuticals
CRBP
$68.1M
| – | – |
-65,201
| Closed | -$612K | – |
|
2986
Carter's
CRI
$1.27B
| – | – |
-1,067,583
| Closed | -$38.2M | – |
|
2987
Cerence
CRNC
$390M
| – | – |
-114,965
| Closed | -$725K | – |
|
2988
Crocs
CROX
$7.33B
| – | – |
-3,088
| Closed | -$337K | – |
|
2989
DELISTED
Cosan
CSAN
| – | – |
-44,529
| Closed | -$183K | – |
|
2990
Carriage Services
CSV
$455M
| – | – |
-6,819
| Closed | -$311K | – |
|
2991
Contango Silver & Gold Inc
CTGO
$553M
| – | – |
-10,613
| Closed | -$199K | – |
|
2992
DELISTED
Cantaloupe
CTLP
| – | – |
-1,187,030
| Closed | -$12.8M | – |
|
|
2993
PUT
DELISTED
Cantaloupe
CTLP
| – | – |
-1,503,700
| Closed | -$16.3M | – |
|
2994
CytomX Therapeutics
CTMX
$432M
| – | – |
-730,844
| Closed | -$3.43M | – |
|
|
2995
CALL
DELISTED
Coterra Energy
CTRA
| – | – |
-1,000,000
| Closed | -$35.1M | – |
|
|
2996
DELISTED
Coterra Energy
CTRA
| – | – |
-8,096,749
| Closed | -$285M | – |
|
2997
PUT
DELISTED
Calavo Growers
CVGW
| – | – |
-317,800
| Closed | -$8.2M | – |
|
2998
CVRx
CVRX
$20.8M
| – | – |
-630,812
| Closed | -$5.97M | – |
|
2999
Curtiss-Wright
CW
$17.3B
| – | – |
-1,523
| Closed | -$1.04M | – |
|
3000
CALL
DELISTED
Clearwater Analytics
CWAN
| – | – |
-3,504,900
| Closed | -$82.9M | – |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.